Despite advances in the understanding of disease pathogenesis, and the increased availability of treatment options, the prevalence of ESRD continues to rise in people living with T2DM [6]
As GLP-1 drugs reshape the global weight-loss industry, the reaction to Williams Super Bowl ad shows a growing discomfort: when icons endorse prescription medicine on the biggest stage in advertising, the conversation quickly shifts from health to responsibility and who should be shaping it.
Emerging formulation strategies for KPV, including PEGylated and liposomal delivery vehicles, aim to extend its 15-minute half-life and improve bioavailability for both injectable and oral contexts
It is believed to improve energy production in cells, enhance mood and cognition, and alleviate nerve pain
GHK has been suggested to quench 4-hydroxy-trans-2-nonenal (4-HNE) and acrolein, both toxic aldehydes generated during lipid peroxidation, suggesting the tripeptide backbone itself may carry electrophile-scavenging capacity independent of its metal-chelating role